HB 172 (2023)
Review redundancy in Prescription Drug Affordability Board duties
Summary:
Directs the Department of Administrative Services, the Insurance Department, and the Department of Health and Human Services to review potential redundancies between existing programs and the Prescription Drug Affordability Board. This bill also directs the Oversight Committee on Health and Human Services to undertake a similar review. Lastly, this bill suspends some of the legal authority of the board for fiscal year 2024.
Bill Became Law?:
No
Status:
Status Detail:
Killed in the House
Public Hearing Date:
01/26/2023 10:00 am
Public Hearing Location:
LOB Room 302-304
House Voting Date:
01/03/2024
Want hearing dates, vote records or the full bill text? See more on the Statehouse website
https://gencourt.state.nh.us/bill_status/billinfo.aspx?id=715&inflect=2
Browse related articles and bills:
